Although more than 30 states have legalized medical marijuana and lawmakers are now working on legislation to federally deschedule cannabis, the industry has constantly been weighed down by prohibition. Thanks to marijuana’s status as a Schedule I controlled substance at the federal level, federal agencies tend to take a hard line against the substance. The Substance Abuse and Mental Services Administration (“SAMHSA”) has in the past taken such a stance, unequivocally stating that its grant funds cannot be used to buy, prescribe and provide cannabis or treatment via medical marijuana.
However, cannabis reform activists will be happy to know that the SAMHSA recently softened the grant funding restrictions concerning medical cannabis. On Aug. 2, 2021, the Pennsylvania Department of Drug and Alcohol Programs (“PDDAP”) noted that there had been a change in the language regarding organizations that are eligible to receive federal grants…
NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.